Day: May 7, 2021

Company announcement no. 23/2021          May 7th, 2021Søren Krogh Knudsen joins Columbus 7 June 2021Company announcement Søren Krogh Knudsen joins Columbus 7 June 2021 As announced in Company announcement no. 20/2021 on 23 April 2021, Columbus’ Board of Directors has appointed Søren Krogh Knudsen as President & CEO of Columbus. Columbus can now announce that Søren Krogh Knudsen will join Columbus on 7 June 2021. “Søren Krogh Knudsen is an experienced international leader within the management consultancy industry with a very strong track record in transformational change and driving profitable growth. He is known for combining strong commercial credentials, management consultancy and an engaging, motivational leadership style. I look very much forward to working with Søren”, said Ib Kunøe, Chairman of the Board. Ib Kunøe                        Chairman...

BEIJING, May 07, 2021 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (NASDAQ: KC) (“Kingsoft Cloud” or the “Company”), a leading independent cloud service provider in China, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2021 before the open of U.S. markets on Tuesday, May 18, 2021. Kingsoft Cloud’s management will host an earnings conference call on Tuesday, May 18, 2021 at 8:00 am, U.S. Eastern Time (8:00 pm, Beijing/Hong Kong Time on the same day). Due to the outbreak of COVID-19, operator assisted conference calls are not available at the moment. All participants must preregister online prior to the call to receive the dial-in details. Preregistration Information Participants can register for the conference call by navigating to http://apac.directeventreg.com/registration/event/7573216....

OKLAHOMA CITY, May 07, 2021 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today announced a change in the location of its 2021 Annual Meeting of Stockholders. In light of continued concerns regarding the COVID-19 pandemic, the Annual Meeting will be held solely by remote communication, in a “virtual-only” format. The previously announced date and time of the meeting (June 9, 2021, at 8:00 a.m. Central Time) have not changed. The Devon Energy Center, including the Devon Energy Center Auditorium where the meeting was to occur, will remain closed to the public through the time of the Annual Meeting. The meeting will be webcast and can be accessed by stockholders at www.virtualshareholdermeeting.com/DVN2021 using the control number on their proxy card, voting instruction form or Notice of Internet Availability of Proxy Materials....

First quarter net income attributable to Icahn Enterprises of $162 million, or $0.65 per depositary unitBoard approves quarterly distribution of $2.00 per depositary unitSUNNY ISLES BEACH, Fla., May 07, 2021 (GLOBE NEWSWIRE) — Icahn Enterprises L.P. (Nasdaq:IEP) is reporting first quarter 2021 revenues of $3.4 billion and net income attributable to Icahn Enterprises of $162 million, or $0.65 per depositary unit. For the three months ended March 31, 2020, revenues were $(60) million and net loss attributable to Icahn Enterprises was $1.4 billion, or a loss of $6.34 per depositary unit. For the three months ended March 31, 2021, Adjusted EBITDA attributable to Icahn Enterprises was $435 million compared to $(1.3) billion for the three months ended March 31, 2020. For the three months ended March 31, 2021, Adjusted EBIT attributable...

LevelX Capital On-line Broker Dealer, LevelX Advisors, and Prodigio RTS Trading Platform Acquired by Investview to Create Exciting New Growth Channel Acquisitions are expected to enable Investview to deliver professional trading services to a diverse base of active online investors, professional fund managers, buy-side professionals, registered investment advisors and other broker-dealers. Eatontown, New Jersey, May 07, 2021 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU), a diversified financial technology company is pleased to announce a series of transformational acquisitions as part of an overall strategy to expand the scope of Investview’s business into complementary, fast-growing adjacent markets. With these acquisitions Investview will immediately enter the fast-growing U.S. and non-U.S. online brokerage industry with...

Conference Call to be held Thursday, May 13, 2021 at 8:30 a.m. Eastern Time AUSTIN, May 07, 2021 (GLOBE NEWSWIRE) — AYRO, Inc. (Nasdaq: AYRO) (“AYRO” or the “Company”), a designer and manufacturer of light-duty, short-haul, and last-mile delivery electric vehicles (EVs), announces today that it will report first quarter 2021 financial results on Thursday, May 13, before the market open. Rod Keller, CEO and Curt Smith, CFO will also host a conference call at 8:30 a.m. ET on Thursday, May 13, 2021 to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question and answer session. To listen to the conference call, interested parties within the U.S. should dial 1-877-270-2148 (domestic) or 1-412-902-6510 (international). All callers should dial in approximately...

BEIJING, May 07, 2021 (GLOBE NEWSWIRE) — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced that it will release financial results for the first quarter ended March 31, 2021, after the close of the stock market on Thursday, May 13, 2021. The Company will discuss those results in a conference call at 9 p.m. ET that same day. Participant Dial-in NumbersU.S. & Canada (Toll-Free): +1 (877) 407-9122International (Toll): +1 (201) 493-6747     Local AccessChina: (400) 120 2840Hong Kong: (800) 965561WebcastThe call will also be made available via online webcast. Investors may access the live webcast at the following link:...

AIPAC reaches ~72% of events and TACTI-002 recruitment is progressing well New data from TACTI-002 and INSIGHT-004 to be reported at ASCO in June 2021 TACTI-003 clinical trial design enables evaluation of efti in 1st line recurrent or metastatic HNSCC patients to better understand its effect in combination with pembrolizumab Robust financial position with cash runway into calendar year 2023, beyond several significant data read-outsSydney, AUSTRALIA, May 07, 2021 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, provides an update on its clinical and preclinical programs. Eftilagimod alpha (“efti”) Update AIPAC – Phase IIb clinical trialThe Company is on track...

CALGARY, Alberta, May 07, 2021 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”) (NASDAQ: DRTT, TSX: DRT) is pleased to announce that all resolutions submitted to shareholders at its annual meeting of shareholders held on May 6, 2021, including the election of all eight nominees proposed as directors and listed in its Management Information Circular and Proxy Statement dated March 25, 2021, have passed. The detailed results of the vote on the election of directors are as follows:Nominee Votes For   Votes Withheld  Number Percent   Number PercentMichael T. Ford 54,516,657 99.53   35,685 0.07Denise E. Karkkainen 48,695,171 89.26   5,857,171 10.74Shauna R. King 53,546,720 98.16   1,005,622 1.84Todd W. Lillibridge 48,695,090 89.26   5,857,252 10.74James A. (Jim) Lynch 54,516,608 99.93   35,734 0.07Kevin...

Study will evaluate safety and immunogenicity of oral norovirus vaccine in elderly population Norovirus represents a significant unmet need in the elderly — there currently is no approved vaccine Safety and immunogenicity data to also inform oral COVID-19 vaccine program in older population SOUTH SAN FRANCISCO, Calif., May 07, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has enrolled the first subject in a Phase 1b placebo-controlled, dose-ranging, repeat dose trial investigating its oral norovirus vaccine candidate in elderly subjects aged 55 – 80 years. This study is designed to evaluate the safety and immunogenicity of Vaxart’s candidate, which is the only clinical...